Characteristics and quality of life of nine-year survivors with metastatic melanoma treated with pembrolizumab beyond second-line therapy

Dugas-Breit, S.; Forschner, A.; Erdmann, M.; Gutzmer, R.; Kahler, K. C.; Holst, I.; Brekner, A.; Franklin, C.; Sindrilaru, A.; Zimmer, L.; Heinzerling, L.; Utikal, J.; Meier, F.; Bender, A.; Berking, C.; Garbe, C.; Weichenthal, M.; Schadendorf, D.; Hauschild, A.; Gschnell, M.; Mohr, P.; Hassel, J. C.

Publication services
→
Universitätsbibliographie
→
4 Medizinische Fakultät
→
View Item

« back

Characteristics and quality of life of nine-year survivors with metastatic melanoma treated with pembrolizumab beyond second-line therapy

Author:

Dugas-Breit, S.; Forschner, A.; Erdmann, M.; Gutzmer, R.; Kahler, K. C.; Holst, I.; Brekner, A.; Franklin, C.; Sindrilaru, A.; Zimmer, L.; Heinzerling, L.; Utikal, J.; Meier, F.; Bender, A.; Berking, C.; Garbe, C.; Weichenthal, M.; Schadendorf, D.; Hauschild, A.; Gschnell, M.; Mohr, P.; Hassel, J. C.

Tübinger Autor(en):

Forschner, Andrea Lydia
Garbe, Claus

Published in:

European Journal of Cancer (2026), Bd. 233, Article 116149

Verlagsangabe:

London : Elsevier Sci Ltd

Language:

English

Full text:

http://dx.doi.org/10.1016/j.ejca.2025.116149

ISSN:

0959-8049